COMBAT-MS is a research project investigating rituximab treatment for MS. We will compare rituximab to all other immunotherapies currently used for MS in a long-term observational study. This study is a collaboration between Kaiser Permanente Southern California (KPSC) and the Karolinska Institutet (KI). It is funded by PCORI for the duration of five years from 2016-2021.
Results of the research February 2019
Although the deadline for the COMBAT-MS project is still a few years away, there are several issues that already can be answered. Here you will find information about the results for completed and currently ongoing projects